| pubmed-article:21402750 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21402750 | lifeskim:mentions | umls-concept:C0001675 | lld:lifeskim |
| pubmed-article:21402750 | lifeskim:mentions | umls-concept:C0015780 | lld:lifeskim |
| pubmed-article:21402750 | lifeskim:mentions | umls-concept:C0524637 | lld:lifeskim |
| pubmed-article:21402750 | lifeskim:mentions | umls-concept:C0442592 | lld:lifeskim |
| pubmed-article:21402750 | lifeskim:mentions | umls-concept:C0011155 | lld:lifeskim |
| pubmed-article:21402750 | lifeskim:mentions | umls-concept:C1710693 | lld:lifeskim |
| pubmed-article:21402750 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:21402750 | pubmed:dateCreated | 2011-5-30 | lld:pubmed |
| pubmed-article:21402750 | pubmed:abstractText | The late presentation of steroid 5?-reductase-2 (SRD5A2) deficiency in females is poorly characterised. The ratios of 5?/5?-reduced metabolites of adrenal steroids in a urine steroid profile (USP) can give an indication of SRD5A2 deficiency, although the diagnostic cut-off for 5?/5? ratios are not clearly defined in genetically confirmed cases. | lld:pubmed |
| pubmed-article:21402750 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21402750 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21402750 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21402750 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21402750 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21402750 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21402750 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21402750 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21402750 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:21402750 | pubmed:issn | 1479-683X | lld:pubmed |
| pubmed-article:21402750 | pubmed:author | pubmed-author:ConwayGerard... | lld:pubmed |
| pubmed-article:21402750 | pubmed:author | pubmed-author:RumsbyGillG | lld:pubmed |
| pubmed-article:21402750 | pubmed:author | pubmed-author:HonourJohn... | lld:pubmed |
| pubmed-article:21402750 | pubmed:author | pubmed-author:CreightonSara... | lld:pubmed |
| pubmed-article:21402750 | pubmed:author | pubmed-author:WilliamsEmma... | lld:pubmed |
| pubmed-article:21402750 | pubmed:author | pubmed-author:BerraMartaM | lld:pubmed |
| pubmed-article:21402750 | pubmed:author | pubmed-author:MuroniBarbara... | lld:pubmed |
| pubmed-article:21402750 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21402750 | pubmed:volume | 164 | lld:pubmed |
| pubmed-article:21402750 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21402750 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21402750 | pubmed:pagination | 1019-25 | lld:pubmed |
| pubmed-article:21402750 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:meshHeading | pubmed-meshheading:21402750... | lld:pubmed |
| pubmed-article:21402750 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21402750 | pubmed:articleTitle | Recognition of 5?-reductase-2 deficiency in an adult female 46XY DSD clinic. | lld:pubmed |
| pubmed-article:21402750 | pubmed:affiliation | Department of Endocrinology, University College London Hospitals, 250 Euston Road, London NW1 2BU, UK. | lld:pubmed |
| pubmed-article:21402750 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:6716 | entrezgene:pubmed | pubmed-article:21402750 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21402750 | lld:entrezgene |
